Evidence-linked intelligence. From doctor conversation to commercial decision.

We recruit and interview oncologists and rare disease specialists across your target markets.

• 45–60 minute adaptive conversations (not 10-minute surveys)

• Clinically grounded dialogue that respects complexity

• Doctors engage because they feel heard, not processed

• Especially valuable: we ask doctors what questions they have for their peers—surfacing unmet needs directly

Compliance built in: Pharma-grade security, privacy, adverse event detection and routing, full audit trails.

Our platform ingests and structures doctor conversations in real time.

• Treatment beliefs and preferences

• Competitive positioning and brand perceptions

• Decision drivers and barriers

• Patterns across markets, specialties, and segments

• Contradictions between what doctors say and what behavior data suggests

Clinical ontologies: Purpose-built for oncology and rare diseases. Our AI is constrained by curated medical taxonomies (indications, biomarkers, regimens, lines of therapy) to prevent hallucinations.

Your teams get instant access to organized, queryable intelligence.

• Interactive dashboards and filters

• Multi-market and multi-segment comparisons

• Trend analysis over time

• Natural language queries: 'What do German oncologists think about X in second-line treatment?'

Evidence traceability: Every AI-generated insight links directly back to the underlying doctor quotes. Your teams can verify and explore the evidence themselves.

Intelligence flows into your existing systems and workflows.

• CRM platforms for next-best-action rules

• BI and analytics stacks for broader analysis

• Reporting tools for stakeholder updates

• API access for custom workflows

Output formats:

• Executive summaries and strategic briefs

• Segmentation frameworks

• Messaging and positioning guidance

• Evidence packages for internal alignment